News

Children with cancer are being denied new drugs because European Union rules are allowing companies to conduct trials on certain drugs only in adults, according to experts from The Institute of Cancer Research in London.

Product helps to determine whether a drug candidate prolongs cardiac repolarization, a surrogate for potentially-fatal arrhythmias

New solution leverages linked data technologies to power the discovery of new scientific and strategic insights